(Q77197716)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11714539%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

title

Bcl-2 is an independent prognostic factor and adds to a biological model for predicting outcome in operable non-small cell lung cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11714539%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

author name string

G Cox

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11714539%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

J Louise Jones

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11714539%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

A Andi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11714539%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

K R Abrams

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11714539%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

K J O'Byrne

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11714539%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

publication date

1 December 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11714539%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11714539%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11714539%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11714539%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

page(s)

417-426

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11714539%20AND%20SRC:MED&resulttype=core&format=json

A biological staging model for operable non-small cell lung cancer

3 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900290-2

7 January 2021

The possible role of bcl-2 expression in the progression of tumors of the uterine cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900290-2

7 January 2021

Expression of the BCL-2 protein in normal and dysplastic bronchial epithelium and in lung carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900290-2

7 January 2021

p53 and bcl-2 expression correlates with clinical outcome in a series of node-positive breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900290-2

7 January 2021

Potential role ofbcl-2 as a suppressor of tumour angiogenesis in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900290-2

7 January 2021

bcl-2 protein in non-small-cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900290-2

7 January 2021

Bcl-2 protein: a prognostic factor inversely correlated to p53 in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900290-2

7 January 2021

Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900290-2

7 January 2021

Immunocytochemical markers in stage I lung cancer: relevance to prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900290-2

7 January 2021

bcl2 and p53 regulate vascular endothelial growth factor (VEGF)-mediated angiogenesis in non-small cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900290-2

7 January 2021

Absence of prognostic significance of bcl-2 immunopositivity in non-small cell lung cancer: analysis of 427 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900290-2

7 January 2021

Bcl-2 immunohistochemistry in a surgical series of non-small cell lung cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900290-2

7 January 2021

The relationship of quantitative epidermal growth factor receptor expression in non-small cell lung cancer to long term survival

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900290-2

7 January 2021

The plasmin cascade and matrix metalloproteinases in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900290-2

7 January 2021

Matrix metalloproteinases in tumour invasion and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900290-2

7 January 2021

Overexpression of epidermal growth factor receptor in human head and neck squamous carcinoma cell lines correlates with matrix metalloproteinase-9 expression and in vitro invasion.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900290-2

7 January 2021

Quantitation and prognostic value of breast cancer angiogenesis: Comparison of microvessel density, Chalkley count, and computer image analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900290-2

7 January 2021

PROGNOSTIC VALUE OF ANGIOGENESIS IN OPERABLE NON-SMALL CELL LUNG CANCER

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900290-2

7 January 2021

Angiogenesis as a Prognostic Indicator of Survival in Non-Small-Cell Lung Carcinoma: a Prospective Study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900290-2

7 January 2021

Prognostic significance of platelet and microvessel counts in operable non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900290-2

7 January 2021

Revisions in the International System for Staging Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900290-2

7 January 2021

The World Health Organization histological typing of lung tumours. Second edition

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900290-2

7 January 2021

Does immunointensity account for the differences in prognostic significance of Bcl-2 expression in non-small cell lung cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900290-2

7 January 2021

Examining the technique of angiogenesis assessment in invasive breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900290-2

7 January 2021

Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900290-2

7 January 2021

Multiple molecular marker testing (p53, C-Ki-ras, c-erbB-2) improves estimation of prognosis in potentially curative resected non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900290-2

7 January 2021

Matrix metalloproteinase inhibition as a novel anticancer strategy: a review with special focus on batimastat and marimastat

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900290-2

7 January 2021

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900290-2

7 January 2021

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900290-2

7 January 2021

10.1016/S0169-5002(01)00290-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11714539%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference